calycosin-7-O-beta-D-glucoside,
ononin,
Ononin,
Formononetin glucoside,
486-62-4,
UNII-Z0Z637970U,
Formononetin 7-O-glucoside,
4'-Methoxyisoflavone-7-O-beta-D-glucopyranoside,
formononetin-7-O-glucoside,
Formononetin-7-O-beta-D-glucopyranoside,
CHEBI:7775,
Z0Z637970U,
3-(4-methoxyphenyl)-4-oxo-4H-chromen-7-yl beta-D-glucopyranoside,
Formononetin 7-O-beta-D-glucopyranoside,
3-(4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one,
Formononetin 7-O-|A-D-glucopyranoside,
AC1L9DFZ,
MLS002473151,
SCHEMBL240476,
CHEMBL465980,
MEGxp0_000395,
7Beta-(Glucosyloxy)Formonometin,
formononetin 7-O-beta-glucoside,
ACon1_000463,
MGJLSBDCWOSMHL-MIUGBVLSSA-N,
HMS2225H24,
Ononin, >=99.0% (TLC),
HY-N0270,
ZINC1081322,
BDBM50409313,
CS-3719,
MCULE-5020661304,
NCGC00169054-01,
AN-45237,
CC-33343,
SMR001397243,
ZB015927,
N1902,
C10509,
C-22242,
BRD-K86699891-001-01-1,
Ononin, United States Pharmacopeia (USP) Reference Standard,
3-(4-methoxyphenyl)-4-oxo-4H-chromen-7-yl .beta.-D-glucopyranoside,
4H-1-Benzopyran-4-one, 7-(beta-D-glucopyranosyloxy)-3-(4-methoxyphenyl)-,
3-(4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one,
3-(4-methoxyphenyl)-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4H-chromen-4-one,
C22H22O9,
CID442813,
ACN-035518,
C22-H22-O9,
4H-1-Benzopyran-4-one,7-(b-D-glucopyranosyloxy)-3-(4-methoxyphenyl)-,